PLUS THERAPEUTICS, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:PSTV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 12.06 M10.35 M18.67 M16.32 M19.92 M Total liabilities 35.7 M7.32 M13.62 M12.33 M7.96 M Total equity -23.64 M3.03 M5.05 M4 M11.96 M Total liabilities & shareholders' equities 12.06 M10.35 M18.67 M16.32 M19.92 M Total debt ————— Net debt —————

News

Plus Therapeutics, Inc. (PSTV) Discusses Rebranding and Integrated CNS Oncology Platform Strategy Transcript

Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates

Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Beats Revenue Estimates

Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering - Slideshow (NASDAQ:PSTV) 2026-01-30

H.C. Wainwright lowers Plus Therapeutics stock price target on equity offering

Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript

Plus Therapeutics outlines 2026 goals for cancer treatments and diagnostics